Royalty Pharma (RPRX) Financial Analysis & Valuation | Quarter Chart

Royalty Pharma (RPRX)

RPRX
Price: $57.09
Fair Value: 🔒
🔒score
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the compa... more
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in... more
Description Shares
Market Cap$24.56BExchangeNASDAQ
SectorHealthcareIndustryBiotechnology
CountryUSCEOPablo Legorreta
IPO Date2020-06-16CAGR0.04%
Employees100Websitewww.royaltypharma.com
Div. Yield1.36%Payout Ratio0.47%
Buy Back Yield1.96%Total Yield3.32%
RPRX chart loading...
Fundamentals Technicals
Enterprise Value$30.20BP/E Ratio11.26
Forward P/E10.17PEG Ratio1.3
P/S Ratio11.87P/B Ratio4.21
P/CF Ratio10.95P/FCF Ratio10.92
EPS$5.07EPS Growth 1Y-23.71%
EPS Growth 3Y227.78%EPS Growth 5Y580.77%
Revenue Growth 1Y7.8%Gross Margin1%
Operating Margin0.68%Profit Margin0.34%
ROE0.13%ROA0.04%
ROCE0.09%Current Ratio2.66
Quick Ratio2.66Cash Ratio1.09
Debt/Equity1.3Interest Coverage4.93
Altman Z Score2.14Piotroski Score7

View Royalty Pharma financial charts →